By NewsDesk, with Agency report,
While being in possession of Marijuana was spelt as crime in many countries, it is a legalised business in Germany, where growing or having garden of cannabis has government strong backing.
As reported, stakes were high when it comes to cannabis in Germany after use of medical marijuana was legalized 2017, with scores of companies lining up to grow it, though parliament was said to have started discussing whether it should be decriminalized for everyone.
To prove how lucrative the business is, a cannabis storage facility in Bad Bramstedt, north of the port city of Hamburg, was reported to have security measures such that could adequately to protect even the country’s gold reserves.
A company that sells medicinal cannabis products Managing Director, Nuuvera Deutschland, Hendrik Knopp, said that the company was meeting standard stipulated which includes an alarm system connected with a police station, a certain wall thickness, and motion and vibration detectors.
“We are meeting the high standards stipulated,”
When asked why all the stringent security, Knopp explained that due to fact that his company delivers cannabis for medicinal purposes, there was need for it to be protected.
As learnt, by April, the federal agency for medicines and medicinal products (BfArM) would be deciding on which companies may grow cannabis in Germany, then pass on the cannabis to pharmacies.
“For Germany, making cannabis available to patients is something new and Nuuvera takes on deliveries of cannabis oil and capsules from its Canadian partner.
He declines to discuss the current procedures about cannabis cultivation, but that it was good that the cannabis agency was working with German thoroughness, given stringent conditions, such to kick out adventurers seeking to make fast money.
“From a medical point of view the advantage is that this makes establishing the dosages easier than with cannabis flowers,” Knopp says. We’re making medical products, not joints.”
The demand for cannabis prescriptions in Germany has for long been under estimated. Cannabis can help patients with chronic pain, multiple sclerosis, AIDS-induced lack of appetite, cancer, Alzheimer’s, nerve conditions, and nausea as a result of chemotherapy.
Knopp said the cannabis agency originally estimated a figure of 5,000 patients being prescribed.
“In the meantime more than 14,000 patients have submitted applications,” he said.
This means that the volume of cannabis so far approved by the agency can scarcely meet the need.
A supply problem may also quickly emerge because demand is rising in many countries.
At BfArM, officials are tight-lipped about the current bid tender process for choosing cannabis growers. “The goal is, starting in 2019, to secure the supply for patients with pharmaceutical-quality cannabis cultivated in Germany,” a spokesman says.
Sources said that beyond the issue of cultivation, the broader question that political parties discussing were whether freeing cannabis for medical purposes was paving way to make it available to everyone.
It was reported that Free Democrats (FDP), far-left Die Linke and environmentalist Greens parties believe that such a move should have already taken place.
Meanwhile, on Thursday, a variety of motions were to be debated for first time in parliament, the move would be followed by further discussion in experts’ committees.
According to reports, the Greens are all set to go with a comprehensive cannabis bill and FDP is advocating model projects for legalisation, while Die Linke wants to put a stop to banning possession of tiny amounts of the drug.
For Head of the Die Linke faction in parliament, Jan Korte: “This is an offer to the other parties to see whether we can at least reach a minimum consensus,” s
Officials stated that the German Cannabis Association was hoping that opposition to cannabis for recreational enjoyment and to decriminalization of consumption would be eroded further.
“It will be seen that not everyone who consumes cannabis winds up in the gutter,” says association director Georg Wurth.
Most recently, he noted, it was the Federation of German Crime Officials (BDK) that caused a sensation when it spoke in favour of legalisation. To date, the authorities had not approved any of the applications submitted by several cities for model projects for the controlled sale of cannabis, Wurth said.
On the other side, addiction therapists are sceptical about legalisation, just as is Marlene Mortler, the federal commissioner for drugs. Both cite the country’s health protection laws and the dangers posed by smoking cannabis.
Nuuvera director, Knopp himself favored model projects for the controlled sale of cannabis for private consumption and for shutting down the illegal supply channels.
“Politicians should summon the courage to try it,” he says.
However, given the expectations that demand for medicinal cannabis will rise further, Knopp has just one caveat about legalisation: “This should not come at the expense of supplying patients.”